Those precluded from coverage through the Bridge program include recipients who already receive GLP-1 medications through Medicare Part D and those who have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease due to their existing potential eligibility through Part D
Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Market Report Scope Source: Polaris Market Research Analysis GLP-1 Market FAQ's The GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034
Many believe extra weight is just about appearancebut inside, its quietly putting your health in danger
Semaglutide, as a GLP-1R agonist, works very similarly to GLP-1 by potentiating glucose-stimulated insulin secretion from the pancreatic -cells while suppressing glucagon secretion by pancreatic -cells [103]
Elbadawy NN, Saad MA, Elfarrash S, Ahmed MAE, Abdelkader NF (2025) The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
We observed that despite both groups consuming a dose of alcohol calculated to raise blood alcohol to 0.1 g/dl (approximately 0.08 g/dl BrAC) 51,52 participants in the GLP-1RA group showed a slowed rise in BrAC and altered the subjective effects of alcohol
